|
RAP2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.16020000000294E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.89460000005393E-06 |
| Normal-vs-Stage2 |
2.482100E-02 |
| Normal-vs-Stage3 |
8.792400E-02 |
| Normal-vs-Stage4 |
1.260060E-02 |
| Stage1-vs-Stage2 |
1.336010E-01 |
| Stage1-vs-Stage3 |
4.505600E-02 |
| Stage1-vs-Stage4 |
6.816200E-01 |
| Stage2-vs-Stage3 |
7.957600E-01 |
| Stage2-vs-Stage4 |
5.033800E-01 |
| Stage3-vs-Stage4 |
4.568400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02770000001795E-06 |
| Normal-vs-AfricanAmerican |
9.174400E-04 |
| Normal-vs-Asian |
1.346190E-01 |
| Caucasian-vs-AfricanAmerican |
5.863000E-01 |
| Caucasian-vs-Asian |
5.237400E-01 |
| AfricanAmerican-vs-Asian |
7.690600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.76279999994667E-07 |
| Normal-vs-Female |
8.035400E-03 |
| Male-vs-Female |
5.880400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.262400E-03 |
| Normal-vs-Extreme_Weight |
4.11499999630749E-08 |
| Normal-vs-Obese |
8.21370000000377E-05 |
| Normal-vs-Extreme_Obese |
5.255600E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.171000E-01 |
| Normal_Weight-vs-Obese |
8.661400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.517800E-01 |
| Extreme_Weight-vs-Obese |
1.996190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.887000E-01 |
| Obese-vs-Extreme_Obese |
8.882600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.218600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.998250E-03 |
| Normal-vs-Age(61-80Yrs) |
2.0275000000014E-06 |
| Normal-vs-Age(81-100Yrs) |
1.770540E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.501200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.399400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.870000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.742300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.834010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.512400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.53070009392786E-10 |
| Normal-VS-Type2 PRCC |
2.221600E-02 |
| Normal-VS-KIRP CIMP |
3.562600E-03 |
| Normal-VS-Unclassified PRCC |
1.188590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.718700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.104000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.794150E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.303440E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.681600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.220430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.441500E-03 |
| Normal-vs-N1 |
7.981700E-02 |
| Normal-vs-N2 |
9.539500E-03 |
| N0-vs-N1 |
5.891800E-01 |
| N0-vs-N2 |
3.187800E-01 |
| N1-vs-N2 |
3.041000E-01 |
|
|
